TOP TIERMARKET NEWSWIRE
News & sentiment

GENMAB A/S ADR (GMAB) — News & AI sentiment

GENMAB A/S ADR (GMAB) news roundup. 1 story in the last 24 hours, 5 in the past week, 12 over 30 days. Average 24-hour sentiment is 50/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. US House Periodic Transaction Reports (90-day window): 1 purchase (~$8K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 50/100
7d stories
5
avg sentiment 51.4/100
30d stories
12
avg sentiment 54.8/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
1
1 buys · 0 sells

Latest stories on GMAB

8h ago
2d ago
6d ago
6d ago
6d ago
Jul 22
Genmab: Multiple Late-Stage Readouts Ahead
Seeking Alpha56 · neutralproduct/pr
Jul 22
TD Cowen upgrades Genmab stock rating on drug pipeline confidence
Investing.com Analyst Ratings63 · neutralanalyst
Jul 22
Jul 8
Jul 7
Jul 6
Health Care Roundup: Market Talk
WSJ Markets50 · neutralgeneral
Jul 1
Jun 29
Jun 29
Jun 17
Jun 16
Jun 15
Jun 15
Jun 13
Jun 11
Jun 11
Truist Assigns Buy Rating to Genmab (GMAB)
Yahoo Finance61 · neutralanalyst
Jun 5
Jun 2
May 21
May 21
Open GMAB in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →